Rhythm Pharmaceuticals (RYTM) director receives RSUs, options and converts 4,712 RSUs
Rhea-AI Filing Summary
RHYTHM PHARMACEUTICALS director Jean Christophe reported equity awards and an RSU conversion into common stock. He received 2,324 restricted stock units, each representing one share of common stock, which fully vest upon the earlier of June 24, 2027 or the day before the 2027 annual meeting, subject to continued service.
He also received stock options for 3,691 shares of common stock at an exercise price of $107.55 per share, vesting on the same schedule and expiring on June 23, 2036. In addition, 4,712 previously granted restricted stock units were exercised and converted into 4,712 shares of common stock, leaving no remaining units from that grant. Following these transactions, he holds 11,712 shares of common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 4,712 shares
Net Buy
4 txns
Insider
JEAN CHRISTOPHE
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 3,691 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 2,324 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 4,712 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,712 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 3,691 shares (Direct);
Restricted Stock Units — 2,324 shares (Direct);
Common Stock — 11,712 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F2. The restricted stock units are fully vested. The restricted stock units have no expiration date.
- F3. The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date.
- F4. The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.
Key Figures
RSU grant: 2,324 units
Option grant size: 3,691 shares
Option exercise price: $107.55 per share
+4 more
7 metrics
RSU grant
2,324 units
Restricted stock units granted to director, each for one common share
Option grant size
3,691 shares
Stock options granted for common stock
Option exercise price
$107.55 per share
Conversion or exercise price of stock options
Option expiration
June 23, 2036
Expiration date of stock options granted
RSUs converted
4,712 units
Restricted stock units exercised into common stock
Common shares after
11,712 shares
Common stock directly held after transactions
RSU grant vesting
June 24, 2027 / pre-2027 meeting
Earlier of date or day before 2027 annual meeting, subject to service
Key Terms
Restricted Stock Units, Stock Option (right to buy), derivative security, vest
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"The options fully vest upon the earlier of June 24, 2027 or before the 2027 meeting"
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vest financial
"The options fully vest upon the earlier of June 24, 2027 or the day"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Rhythm Pharmaceuticals (RYTM) director Jean Christophe receive?
Jean Christophe received 2,324 restricted stock units and stock options for 3,691 shares at $107.55 per share. Both awards vest by June 24, 2027 or the day before the 2027 annual meeting, subject to his continued service on the board.
What happened to the 4,712 restricted stock units in Jean Christophe’s Rhythm (RYTM) filing?
4,712 restricted stock units were exercised and converted into 4,712 shares of Rhythm common stock. This transaction is coded as an exercise of a derivative security, leaving no remaining units from that specific RSU grant outstanding after the conversion.
When do Jean Christophe’s new Rhythm (RYTM) RSUs and options vest?
Both the 2,324 restricted stock units and the 3,691 stock options vest upon the earlier of June 24, 2027 or the day immediately prior to Rhythm’s 2027 annual shareholder meeting, provided Jean Christophe continues serving as a director through the applicable vesting date.
What is the exercise price and expiration date of Jean Christophe’s Rhythm (RYTM) options?
Jean Christophe’s newly granted stock options cover 3,691 shares of Rhythm common stock at an exercise price of $107.55 per share. These options expire on June 23, 2036, giving a long-dated window once vesting conditions tied to board service are met.